XML 96 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Shareholders Equity - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interests
Beginning balance at Dec. 31, 2019 $ 9,367.6 $ 3.8 $ 858.4 $ 9,921.5 $ (1,598.2) $ 182.1
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2019   378,800,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) 450.4     666.1 (208.0) (7.7)
Stock Issued During Period, Shares, Restricted Stock Award, Gross   300,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (2.7)   (2.7)      
Stock based compensation 17.1   17.1      
Dividends, Common Stock, Cash       (76.6)    
Dividends for noncontrolling interests (76.6)          
Noncontrolling Interest, Increase from Subsidiary Equity Issuance (0.6)         0.6
Ending balance at Dec. 31, 2020 9,755.2 $ 3.8 872.8 10,511.0 (1,806.2) 173.8
Common stock shares outstanding, ending balance (in shares) at Dec. 31, 2020   379,100,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) 1,547.5     1,630.6 (85.6) 2.5
Stock Issued During Period, Shares, Restricted Stock Award, Gross   800,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (11.3)   (11.3)      
Stock based compensation $ 26.4   $ 26.4      
The total intrinsic value of options exercised during the fiscal year 3,200,000   3,200,000      
Stock Repurchased During Period, Shares (11,200,371) (11,200,000)        
Stock Repurchased During Period, Value $ (410.9) $ 0.1 $ (410.8)      
Dividends, Common Stock, Cash (127.4)     (127.4)    
Dividends for noncontrolling interests (31.3)         (31.3)
Noncontrolling Interest, Increase from Subsidiary Equity Issuance (2.9)   2.3     0.6
Ending balance at Dec. 31, 2021 $ 10,748.5 $ 3.7 478.0 12,014.2 (1,891.8) 144.4
Common stock shares outstanding, ending balance (in shares) at Dec. 31, 2021 368,732,231 368,700,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) $ 3,355.6     3,582.8 (260.4) 33.2
Stock Issued During Period, Shares, Restricted Stock Award, Gross   1,200,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (19.2)   (19.2)      
Stock based compensation $ 31.5   $ 31.5      
The total intrinsic value of options exercised during the fiscal year 16,000,000.0   16,000,000.0      
Stock Repurchased During Period, Shares (30,810,173) (30,800,000)        
Stock Repurchased During Period, Value $ (1,673.2) $ 0.3 $ (506.3)      
Dividends, Common Stock, Cash (227.0)     (227.0)    
Dividends for noncontrolling interests (38.0)         (38.0)
Ending balance at Dec. 31, 2022 $ 12,194.2 $ 3.4 $ 0.0 14,203.4 $ (2,152.2) $ 139.6
Common stock shares outstanding, ending balance (in shares) at Dec. 31, 2022 339,071,423 339,100,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock Repurchased and Retired During Period, Value       $ (1,166.6)